When a front group for insurers and drug cost middlemen promote a poll on drug pricing, everyone’s immediate reaction should include a healthy dose of skepticism. The same is true for a poll from the Campaign for Sustainable Rx Pricing, a group funded by the insurance lobby and pharmacy benefit managers – the same people who determine what patients pay at the pharmacy for prescription medicines.
